Consumer Retailing Healthcare Sector

Neuphoria Therapeutics

Market Cap: US$10.9m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

LexaGene Holdings

Market Cap: CA$14.8m

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.

KRTL Holding Group

Market Cap: US$10.8m

KRTL Holding Group, Inc, a beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally.

Telescope Innovations

Market Cap: CA$14.8m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

NuGen Medical Devices

Market Cap: CA$14.8m

A specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally.

Promisia Healthcare

Market Cap: NZ$17.7m

Engages in the aged care and retirement living business in New Zealand.

Athira Pharma

Market Cap: US$10.6m

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

REMSleep Holdings

Market Cap: US$10.5m

A medical technology company, focuses on the development and distribution of products to help people affected by sleep apnea worldwide.

OncoSil Medical

Market Cap: AU$16.1m

A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe.

Cyclerion Therapeutics

Market Cap: US$10.4m

A biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.

Firebrick Pharma

Market Cap: AU$16.1m

Engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia.

Hemogenyx Pharmaceuticals

Market Cap: UK£7.7m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.

STRATA Skin Sciences

Market Cap: US$10.3m

A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.

Nanollose

Market Cap: AU$15.9m

A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.

Fusion Antibodies

Market Cap: UK£7.6m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

Pacific Health Care Organization

Market Cap: US$10.3m

Operates as a workers’ compensation cost containment company in the United States.

Emyria

Market Cap: AU$15.7m

Engages in delivering and developing of new treatments for unmet needs in mental health and select neurological conditions in Australia.

Inhibitor Therapeutics

Market Cap: US$10.2m

A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.

Minerva Neurosciences

Market Cap: US$10.1m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Dogwood Therapeutics

Market Cap: US$10.1m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.

Pharmala Biotech Holdings

Market Cap: CA$13.7m

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Aptamer Group

Market Cap: UK£7.4m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

TruScreen Group

Market Cap: NZ$16.6m

Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally.

Cizzle Biotechnology Holdings

Market Cap: UK£7.3m

Develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom.

Pharma-Bio Serv

Market Cap: US$9.9m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Immuron

Market Cap: AU$15.2m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Guided Therapeutics

Market Cap: US$9.9m

A medical technology company, develops medical devices.

ReNerve

Market Cap: AU$15.0m

A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.

BioCardia

Market Cap: US$9.7m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

RUA Life Sciences

Market Cap: UK£7.1m

Engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally.

Rafarma Pharmaceuticals

Market Cap: US$9.6m

A multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.

Healixa

Market Cap: US$9.5m

Operates as a technology company with assets in both healthtech and fintech.

DIH Holding US

Market Cap: US$9.4m

Operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific.

Kairos Pharma

Market Cap: US$9.4m

A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.

Kiora Pharmaceuticals

Market Cap: US$9.3m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

HCW Biologics

Market Cap: US$9.3m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.